1 / 10

Next step in Iranian Clinical Trial Registration movement

Next step in Iranian Clinical Trial Registration movement. Masoud Solaymani-Dodaran MD MPH PhD CCT FFPH. In this presentation. The international movement How it started and where it is The Iranian movement How it started and where it is International visibility IRCT performance

hertz
Download Presentation

Next step in Iranian Clinical Trial Registration movement

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Next step in Iranian Clinical Trial Registration movement Masoud Solaymani-Dodaran MD MPH PhD CCT FFPH

  2. In this presentation • The international movement • How it started and where it is • The Iranian movement • How it started and where it is • International visibility • IRCT performance • Prospective versus retrospective • Is there any room for improvement?

  3. ICMJE initiative International Committee of Medical Journal Editors ICMJE September 2004: first statement simultaneously published in eleven ICMJE member medical journal The ICMJE member journals will not consider a trial for publication unless it has already been registered in a public trials registry. Trials must register at or before the onset of patient enrollment. October 2004, Health ministers in WHO endorse the idea WHO tasked with creation of Primary Registry Network

  4. What is a WHO primary registry? They are publicly accessible clinical trial registries which have been approved by WHO WHO Primary Registries meet specific criteria for content, quality and validity, accessibility, unique identification, technical capacity and administration Not for profit, digitally searchable, accessible all the time, any responsible registrant can register, information recorded in English, at least 20 items are recorded from each trial, etc

  5. Iranian Registry of Clinical Trials We are the 9th Registry in WHO Primary Registry Network 4th of December 2008 (IRCT became a primary register) 7th of April 2009 (IRCT became a data provider to ICTRP 3200 application to IRCT until Autumn 1389 951 trials has been approved 1st of Day 1388 (Dec 2009) as the deadline for prospective registration of all trials in Iran, otherwise it won’t be published in Iranian journals Signing a Research contract for a trial using public funding is subject to registration in IRCT

  6. IRCT performance

  7. Definition of Retrospective Trial start date Prospective Retrospective What is next for IRCT?

  8. Definition of Retrospective Trial end date Prospective Retrospective Is there any room for improvement?

  9. How much?

  10. How can this happen • Lets get the message out for prospective registration • The registration process should become faster • Regulation? Penalty? • Lets not forget how far we have come but there is still a long way to go

More Related